{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:56:42Z","timestamp":1740149802625,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T00:00:00Z","timestamp":1623110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T00:00:00Z","timestamp":1623110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s12328-021-01460-0","type":"journal-article","created":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T04:02:47Z","timestamp":1623124967000},"page":"1561-1566","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pyoderma gangrenosum with primary sclerosing cholangitis-associated colitis successfully treated with concomitant granulocyte and monocyte adsorption apheresis with corticosteroids"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9784-1487","authenticated-orcid":false,"given":"Munenori","family":"Kawai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiharu","family":"Kawanami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihisa","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Seno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,8]]},"reference":[{"key":"1460_CR1","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1034\/j.1600-0560.2003.00024.x","volume":"30","author":"AN Crowson","year":"2003","unstructured":"Crowson AN, Mihm MC Jr, Magro C. Pyoderma gangrenosum: a review. J Cutan Pathol. 2003;30:97\u2013107.","journal-title":"J Cutan Pathol"},{"key":"1460_CR2","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S0140-6736(97)10187-8","volume":"351","author":"JP Callen","year":"1998","unstructured":"Callen JP. Pyoderma gangrenosum. Lancet. 1998;351:581\u20135.","journal-title":"Lancet"},{"issue":"6","key":"1460_CR3","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1177\/0141076814534407","volume":"107","author":"A Teagle","year":"2014","unstructured":"Teagle A, Hargest R. Management of pyoderma gangrenosum. J R Soc Med. 2014;107(6):228\u201336.","journal-title":"J R Soc Med"},{"key":"1460_CR4","doi-asserted-by":"publisher","first-page":"adv00431","DOI":"10.2340\/00015555-3776","volume":"101","author":"L Sch\u00f8sler","year":"2021","unstructured":"Sch\u00f8sler L, Fogh K, Bech R. Pyoderma gangrenosum: a retrospective study of clinical charac-teristics, comorbidities, response to treatment and mortality related to prednisone dose. Acta Derm Venereol. 2021;101:adv00431.","journal-title":"Acta Derm Venereol"},{"key":"1460_CR5","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1111\/j.1572-0241.2001.03756.x","volume":"96","author":"CN Bernstein","year":"2001","unstructured":"Bernstein CN, Blanchard JF, Yu N, et al. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol. 2001;96:1116\u201322.","journal-title":"Am J Gastroenterol"},{"key":"1460_CR6","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2310\/7750.2013.13103","volume":"18","author":"AV Weizman","year":"2014","unstructured":"Weizman AV, Huang B, Melmed GY, et al. Pyoderma gangrenosum among patients with inflammatory bowel disease: a descriptive cohort study. J Cutan Med Surg. 2014;18:361.","journal-title":"J Cutan Med Surg"},{"key":"1460_CR7","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.autrev.2014.01.028","volume":"13","author":"K Conrad","year":"2014","unstructured":"Conrad K, Roggenbuck D, Laass MW. Diagnosis and classification of ulcerative colitis. Autoimmun Rev. 2014;13:463\u20136.","journal-title":"Autoimmun Rev"},{"key":"1460_CR8","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1038\/jid.2012.130","volume":"132","author":"SM Langan","year":"2012","unstructured":"Langan SM, Groves RW, Gulliford MC, et al. Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: a retrospective cohort study. J Invest Dermatol. 2012;132:2166\u201370.","journal-title":"J Invest Dermatol"},{"key":"1460_CR9","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","volume":"56","author":"K Boonstra","year":"2012","unstructured":"Boonstra K, Beuers U, Ponsioen CY. Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. J Hepatol. 2012;56:1181\u20138.","journal-title":"J Hepatol"},{"key":"1460_CR10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1046\/j.1526-0968.2003.00012.x","volume":"7","author":"AR Saniabadi","year":"2003","unstructured":"Saniabadi AR, Hanai H, Lofberg R, et al. Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes. Ther Apher Dial. 2003;7:48\u201359.","journal-title":"Ther Apher Dial"},{"key":"1460_CR11","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/BF02347507","volume":"30","author":"K Sawada","year":"1995","unstructured":"Sawada K, Ohnishi K, Fukui S, et al. Leukocytapheresis therapy, performed with leukocyte removal filter, for inflammatory bowel disease. J Gastroenterol. 1995;30:322\u20139.","journal-title":"J Gastroenterol"},{"key":"1460_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jca.1000","volume":"16","author":"T Shimoyama","year":"2001","unstructured":"Shimoyama T, Sawada K, Saniabadi AR, et al. Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study. J Clin Apher. 2001;16:1\u20139.","journal-title":"J Clin Apher"},{"key":"1460_CR13","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1067\/mjd.2002.120597","volume":"47","author":"T Kanekura","year":"2002","unstructured":"Kanekura T, Maruyama I, Kanzaki T. Granulocyte and monocyte adsorption apheresis for pyoderma gangrenosum. J Am Acad Dermatol. 2002;47:320\u20131.","journal-title":"J Am Acad Dermatol"},{"key":"1460_CR14","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1111\/j.1572-0241.2003.07657.x","volume":"98","author":"T Ohmori","year":"2003","unstructured":"Ohmori T, Yamagiwa A, Saniabadi AR, et al. Treatment of pyoderma gangrenosum associated with Crohn\u2019s disease. Am J Gastroenterol. 2003;98:2101\u20132.","journal-title":"Am J Gastroenterol"},{"key":"1460_CR15","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1097\/01.MIB.0000172558.39767.b7","volume":"11","author":"R Yanaru-Fujisawa","year":"2005","unstructured":"Yanaru-Fujisawa R, Matsumoto T, Mibu R, et al. Granulocyte apheresis for pouchitis with arthritis and pyoderma gangrenosum after restorative proctocolectomy for ulcerative colitis: a case report. Inflamm Bowel Dis. 2005;11:780\u20131.","journal-title":"Inflamm Bowel Dis"},{"key":"1460_CR16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1744-9987.2007.00424.x","volume":"11","author":"M Seishima","year":"2007","unstructured":"Seishima M, Mizutani Y, Shibuya Y, Nagasawa C, Aoki T. Efficacy of granulocyte and monocyte adsorption apheresis for three cases of refractory pyoderma gangrenosum. Ther Apher Dial. 2007;11:177\u201382.","journal-title":"Ther Apher Dial"},{"key":"1460_CR17","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1038\/ajg.2009.271","volume":"104","author":"T Kawakami","year":"2009","unstructured":"Kawakami T, Yamazaki M, Soma Y. Reduction of interleukin-6, interleukin-8, and anti-phosphatidylserine-prothrombin complex antibody by granulocyte and monocyte adsorption apheresis in a patient with pyoderma gangrenosum and ulcerative colitis. Am J Gastroenterol. 2009;104:2363\u20134.","journal-title":"Am J Gastroenterol"},{"key":"1460_CR18","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1684\/ejd.2011.1461","volume":"21","author":"K Ikeda","year":"2011","unstructured":"Ikeda K, Hamada T, Iwatsuki K, et al. Beneficial effects of neutrophil-targeted therapy for pyoderma gangrenosum associated with ulcerative colitis. Eur J Dermatol. 2011;21:804\u20135.","journal-title":"Eur J Dermatol"},{"key":"1460_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2169\/internalmedicine.55.5422","volume":"55","author":"M Ohno","year":"2016","unstructured":"Ohno M, Koyama S, Ohara M, Shimamoto K, Kobayashi Y, Nakamura F, Mitsuru K, Andoh A. Pyoderma gangrenosum with ulcerative colitis successfully treated by the combination of granulocyte and monocyte adsorption apheresis and corticosteroids. Intern Med. 2016;55:25\u201330.","journal-title":"Intern Med"},{"key":"1460_CR20","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.12998\/wjcc.v8.i11.2092","volume":"8","author":"K Tominaga","year":"2020","unstructured":"Tominaga K, Kamimura K, Terai S, et al. Cytapheresis for pyoderma gangrenosum associated with inflammatory bowel disease: a review of current status. World J Clin Cases. 2020;8:2092\u2013101.","journal-title":"World J Clin Cases"},{"key":"1460_CR21","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1093\/ecco-jcc\/jjw032","volume":"10","author":"A Dignass","year":"2016","unstructured":"Dignass A, Akbar A, Bonaz B, et al. Safety and efficacy of granulocyte\/monocyte apheresis in steroid-dependent active ulcerative colitis with insufficient response or intolerance to immunosuppressants and\/or biologics [the ART trial]: 12-week interim results. J Crohns Colitis. 2016;10:812\u201320.","journal-title":"J Crohns Colitis"},{"key":"1460_CR22","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/1744-9987.12818","volume":"23","author":"K Yanagisawa","year":"2019","unstructured":"Yanagisawa K, Murakami M, Ikezoe M, et al. Efficacy and safety of adsorptive granulocyte and monocyte apheresis in elderly and pregnant patients with ulcerative colitis. Ther Apher Dial. 2019;23:217\u201323.","journal-title":"Ther Apher Dial"},{"key":"1460_CR23","doi-asserted-by":"publisher","first-page":"369","DOI":"10.12998\/wjcc.v4.i11.369","volume":"4","author":"Y Watanabe","year":"2016","unstructured":"Watanabe Y, Kamimura K, Terai S, et al. Case of severe alcoholic hepatitis treated with granulocytapheresis. World J Clin Cases. 2016;4:369\u201374.","journal-title":"World J Clin Cases"},{"key":"1460_CR24","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/1346-8138.12501","volume":"41","author":"T Mabuchi","year":"2014","unstructured":"Mabuchi T, Manabe Y, Yamaoka H, Ota T, Kato M, Ikoma N, Kusakabe Y, Komaba H, Ozawa A. Case of generalized pustular psoriasis with end-stage renal disease successfully treated with granulocyte monocyte apheresis in combination with hemodialysis. J Dermatol. 2014;41:521\u20134.","journal-title":"J Dermatol"},{"key":"1460_CR25","first-page":"985","volume":"15","author":"T Tabuchi","year":"1995","unstructured":"Tabuchi T, Ubukata H, Soma T, et al. Granulocytapheresis as a possible cancer treatment. Anticancer Res. 1995;15:985\u201390.","journal-title":"Anticancer Res"},{"key":"1460_CR26","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1111\/j.1440-1746.2008.05595.x","volume":"23","author":"G Bresci","year":"2008","unstructured":"Bresci G, Parisi G, Capria A, et al. Granulocytapheresis versus methylprednisolone in patients with acute ulcerative colitis: 12-month follow up. J Gastroenterol Hepatol. 2008;23:1678\u201382.","journal-title":"J Gastroenterol Hepatol"},{"key":"1460_CR27","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.gcb.2010.08.007","volume":"34","author":"T Tanaka","year":"2010","unstructured":"Tanaka T, Okanobu H, Oya T, et al. Clinical and endoscopic features of responders and non-responders to adsorptive leucocytapheresis: a report based on 120 patients with active ulcerative colitis. Gastroenterol Clin Biol. 2010;34:687\u201395.","journal-title":"Gastroenterol Clin Biol"},{"key":"1460_CR28","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1007\/s10620-006-9199-9","volume":"51","author":"Y Suzuki","year":"2006","unstructured":"Suzuki Y, Yoshimura N, Saniabadi AR, et al. A retrospective search for predictors of clinical response to selective granulocyte and monocyte apheresis in patients with ulcerative colitis. Dig Dis Sci. 2006;51:2031\u20138.","journal-title":"Dig Dis Sci"},{"key":"1460_CR29","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1471-230X-10-73","volume":"10","author":"A Lindberg","year":"2010","unstructured":"Lindberg A, Eberhardson M, Karlsson M, Karl\u00e9n P. Long-term follow-up with granulocyte and monocyte apheresis re-treatment in patients with chronically active inflammatory bowel disease. BMC Gastroenterol. 2010;10:73.","journal-title":"BMC Gastroenterol"},{"key":"1460_CR30","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1007\/s10620-013-2762-2","volume":"58","author":"F Arg\u00fcelles-Arias","year":"2013","unstructured":"Arg\u00fcelles-Arias F, Castro-Laria L, Herrer\u00edas-Guti\u00e9rrez JM, et al. Characteristics and treatment of pyoderma gangrenosum in inflammatory bowel disease. Dig Dis Sci. 2013;58:2949\u201354.","journal-title":"Dig Dis Sci"},{"key":"1460_CR31","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/ijd.13591","volume":"56","author":"AS Vacas","year":"2017","unstructured":"Vacas AS, Torre AC, Galimberti RL, et al. Pyoderma gangrenosum: clinical characteristics, associated diseases, and responses to treatment in a retrospective cohort study of 31 patients. Int J Dermatol. 2017;56:386\u201391.","journal-title":"Int J Dermatol"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-021-01460-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12328-021-01460-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-021-01460-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T15:14:33Z","timestamp":1631546073000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12328-021-01460-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,8]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["1460"],"URL":"https:\/\/doi.org\/10.1007\/s12328-021-01460-0","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"type":"print","value":"1865-7257"},{"type":"electronic","value":"1865-7265"}],"subject":[],"published":{"date-parts":[[2021,6,8]]},"assertion":[{"value":"30 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Munenori Kawai, Chiharu Kawanami, Akihisa Fukuda and Hiroshi Seno declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human rights"}},{"value":"We confirmed that the patient have given her Informed Consent and that there will be no problem publishing.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}